World Hepatitis Day 2020

World Hepatitis Day is commemorated each year on 28 July to enhance awareness of viral hepatitis, an inflammation of the liver that causes a range of health problems, including liver cancer. There are five main strains of the hepatitis virus – A, B, C, D and E. Together, hepatitis B and C are the most common cause of deaths, with 1.3 million lives lost each year. Amid the COVID-19 pandemic, viral hepatitis continues to claim

Dual Pandemics – What Will COVID-19 Mean for Hepatitis C Elimination?


Australia is a world leader in its efforts to eliminate hepatitis C and to improve the health of people who use drugs. But COVID-19, on a backdrop of economic uncertainty, anxiety and unemployment has the potential to disrupt our support, prevention and cure efforts – especially given the populations most impacted by hepatitis C and drug dependence are some of our most vulnerable Australians. 

9th International Conference on Hepatitis Care in Substance Users

Glasgow, United Kingdom,

The 9th International Conference on Hepatitis Care in Substance Users will be held in Glasgow, Scotland, 8 – 10 October 2020.

The INHSU annual conference is a unique opportunity to connect with the global community working to improve health outcomes for people who use drugs including the prevention, treatment and care of hepatitis C.

Monitoring the Elimination of Viral Hepatitis as a Public Health Threat in Europe

Published by

This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID).

The barometer is being developed by the EMCDDA together with its expert network on drug-related infectious diseases (DRID), as a follow-up to the first global health sector strategy on viral hepatitis endorsed by the World Health Assembly in 2016.

3rd European Chemsex Forum

Paris, France,

The 3rd European Chemsex Forum will be a 2½ day, multi-disciplinary event, in Paris, 14-16 November 2019.

Activities include an evening opening with keynote speeches on Thursday, the Data and Evidence Day on Friday, and the Community Mobilisation Day on Saturday.

8th International Conference on Hepatitis Care in Substance Users


The 8th INHSU conference covers the latest advances on hepatitis C epidemiology, management and treatment of viral hepatitis among people who use drugs, with a specific focus on hepatitis C.

Through the dissemination of scientific knowledge, the conference aims to contribute to the World Health Organization’s goal of eliminating hepatitis C by 2030.

HepHIV2019 Conference

Bucharest, Romania,

The HepHIV2019 conference, which is organised jointly with the 3-year EU funded joint action INTEGRATE, will take place 28-30 January 2019 in Bucharest, Romania.

The theme of the conference is the Challenges of Timely and Integrated Testing and Care.

The main objectives of the HepHIV 2019 conference are to:

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016

Campbell CA, Canary L, Smith N, Teshale E, Ryerson AB, Ward JW. State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016. MMWR Morb Mortal Wkly Rep 2017;66:465–469. DOI: http://dx.doi.org/10.15585/mmwr.mm6618a2
Publication Date


What is already known about this topic?

The United States has experienced a sharp increase in hepatitis C virus (HCV) incidence that can be attributed to injection drug use. Some states have used public health laws and treatment policies to reduce the risk for transmission of HCV infections among persons who inject drugs.

What is added by this report?